MAPT and Alzheimer disease: In addition, [11C]-PBB3 [107] has demonstrated being able to differentiate AD patients from healthy controls, and is able to detect Tau aggregates in subjects with dementias not related to Alzheimer’s disease; however, this compound poorly discriminated among Tau/Aβ deposits [108].